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Abstract
Background: Providing women with contraceptive methods following abortion is important to reduce repeat
abortion rates, yet evidence for effective post-abortion family planning interventions are limited. This protocol
outlines the evaluation of a mobile phone-based intervention using voice messages to support post-abortion
family planning in Cambodia.
Methods/Design: A single blind randomised controlled trial of 500 participants. Clients aged 18 or over, attending
for abortion at four Marie Stopes International clinics in Cambodia, owning a mobile phone and not wishing to
have a child at the current time are randomised to the mobile phone-based intervention or control (standard care)
with a 1:1 allocation ratio.
The intervention comprises a series of six automated voice messages to remind clients about available family
planning methods and provide a conduit for additional support. Clients can respond to message prompts to
request a phone call from a counsellor, or alternatively to state they have no problems. Clients requesting to talk to
a counsellor, or who do not respond to the message prompts, receive a call from a Marie Stopes International
Cambodia counsellor who provides individualised advice and support regarding family planning. The duration of
the intervention is 3 months. The control group receive existing standard of care without the additional mobile
phone-based support.
We hypothesise that the intervention will remind clients about contraceptive methods available, identify problems
with side effects early and provide support, and therefore increase use of post-abortion family planning, while
reducing discontinuation and unsafe method switching.
Participants are assessed at baseline and at 4 months. The primary outcome measure is use of an effective modern
contraceptive method at 4 months post abortion. Secondary outcome measures include contraception use,
pregnancy and repeat abortion over the 4-month post-abortion period.
Risk ratios will be used as the measure of effect of the intervention on the outcomes, and these will be estimated
with 95% confidence intervals. All analyses will be based on the ‘intention to treat’ principle.
Discussion: This study will provide evidence on the effectiveness of a mobile phone-based intervention using voice
messages to support contraception use in a population with limited literacy. Findings could be generalisable to
similar populations in different settings.
Trial registration number: ClinicalTrials.gov Identifier: NCT01823861
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Background
Globally, an estimated 44 million pregnancies end in
abortion each year, of which nearly half are unsafe,
resulting in 47,000 maternal deaths [1,2]. The vast ma-
jority of unsafe abortions occur in developing countries
and account for one in eight maternal deaths. Around
80% of unintended pregnancies in developing countries
occur among women who have an unmet need for mod-
ern family planning (FP) [1]. Globally, if unmet need for
FP were met, an estimated 75% of unsafe abortions
could be avoided [3].
The 2010 Cambodia Demographic Health Survey
(CDHS) reported that 81% of women of reproductive
age did not want any more children, or wished to wait at
least 2 years for their next child, but only 35% were
using a modern method of contraception [4]. Modern
methods include condom, oral contraceptive (OC), in-
jectable, implant, intra-uterine device (IUD) and per-
manent methods: vasectomy and sterilisation. The low
use of contraception might contribute towards the high
abortion rate in Cambodia, estimated at 50 per 1,000
women, well above the global average of 28 per 1,000
[5]. Furthermore, among women who have had an abor-
tion, 26% have had more than one.
This highlights the need for more effective interven-
tions to support clients with post-abortion family plan-
ning (PAFP).
There has been widespread uptake of mobile phones
in low-income countries including Cambodia, with an
estimated 19 million mobile subscriptions covering a
population of approximately 14 million in 2012 [6]. Ma-
rie Stopes International Cambodia (MSIC) client exit
surveys have estimated that over 80% of abortion clients
own a mobile phone. The use of mobile phones to de-
liver healthcare (‘mHealth’) has the advantage over face-
to-face healthcare delivery in that support can be deliv-
ered inexpensively wherever the person is located, when
it is needed. This is of particular relevance in Cambodia
where the women least likely to use a modern method
of contraception are the rural poor [4]. Behaviour
change techniques (BCTs) used in face-to-face interven-
tions can be modified for delivery via mobile phones [7].
Previous trials related to smoking cessation and HIV
have reported objective evidence of altered health
behaviour leading to improved health outcomes [8,9],
yet there is more limited evidence related to the use of
contraception.
Of the three previous trials in the USA to improve
contraceptive use, Kirby (2010) reported no effect on
contraception use with phone calls using motivational
interviewing techniques [10], and Hou (2010) reported
no significant difference in mean numbers of missed
pills with simple daily SMS reminders [11]. However, in
a larger trial (n = 962), Castano (2010) reported that
participants receiving daily educational text messages
and pill reminders remained more likely to continue at
6 months (OR 1.41, 1.02-1.95) [12].
There is even less evidence for PAFP. No studies have
formally reported mHealth PAFP interventions in low-
income countries, although the ‘m-assist: Mobile in
Medical Abortion’ trial has provisionally reported in-
creased IUD uptake (21% vs. 13%) at 7 weeks post abor-
tion with a post-abortion SMS-based intervention in
South Africa [13]. Although these study results look
promising, to date, the effect of mHealth interventions
on PAFP, or on a wider range of contraceptive methods,
has not been reliably established.
The MObile Technology for Improved Family Plan-
ning (MOTIF) project comprises the development, im-
plementation and evaluation of a mobile phone-based
intervention to support PAFP in Cambodia. This proto-
col outlines our proposed evaluation of the intervention
developed.
Methods/Design
Study design
MOTIF is a multisite single-blind randomised controlled
trial (RCT). Participants are randomised to the mobile
phone-based intervention (voice messages and follow-up
phone calls) or standard of care (SOC)/control (no add-
itional mobile phone-based support) with a 1:1 alloca-
tion ratio (see Figure 1).
Setting and participants
Participants are recruited from four MSIC clinics; two
serving predominantly urban populations around Phnom
Penh City (Chbar Ambov and Takmao), and two based
in provincial towns serving predominantly rural popula-
tions (Battambang and Siem Reap). Participants are eli-
gible for the trial if they are attending for induced
abortion, aged 18 years or over, own a mobile phone, do
not want to have a child at the present time and are will-
ing to receive simple voice messages from MSIC related
to contraception. Clients are eligible regardless of
whether they have decided to adopt PAFP after their
abortion.
Potential trial participants are identified by service
providers in the clinics who ask whether they would like
to discuss participation in the trial with a research assist-
ant (RA) at the end of the PAFP counselling session.
RAs provide further information regarding the study.
Given the high rates of illiteracy in Cambodia (literacy in
rural areas was 69% according to the 2010 Cambodia
DHS), the RA verbally explains the study by reading the
Participants Information Sheet [4]. If the client wishes to
participate, they sign, or thumbprint, two copies of the
consent form. RAs collect baseline data from partici-
pants that are recruited. The RA provides a written list
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of all participants recruited, together with a unique trial
identification (ID) number, to the counsellor delivering
the intervention. The RA sends only the ID number to-
gether with the clinic status (‘urban’ or ‘rural’) of en-
rolled participants to a project statistician at the London
School of Hygiene and Tropical Medicine (LSHTM) via
email. Participants are stratified according to urban or
rural clinic status and allocated to the intervention or
control group using a remote computer-based random-
isation programme. Allocation is therefore concealed
from RAs working on the trial.
Intervention
The intervention was developed following a review of
the literature, formative research including interviews
and focus groups with abortion clients, and with input
from clinicians and technology partners in Cambodia
[14].
The intervention has a similar basis to the approach
used by Lester (2010) in Kenya who hypothesised that a
structured mobile phone protocol to keep in touch with
patient could improve HIV medication adherence [15].
Detailed description of the intervention development
will be reported elsewhere.
The MOTIF conceptual framework is based on exist-
ing literature on the determinants of contraceptive use,
links between contraceptive use and fertility, and effect-
ive adherence interventions (Figure 2) [16,17].
The MOTIF intervention comprises a series of automated
voice messages to participants’ mobile phones over the
3-month period following their abortion, at times of their
preference. Clients receive the first message within 1 week
of receiving abortion services and then every 2 weeks, with a
total of six messages. The messages are designed to remind
clients about FP methods available to them and provide a
conduit for additional support. A typical message, recorded
in the Cambodian (Khmer) language, is as follows:
Figure 1 CONSORT diagram of study design.
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‘Hello, this is a voice message from a Marie Stopes
counsellor. I hope you are doing fine. Contraceptive
methods are an effective and safe way to prevent
unplanned pregnancy. I am waiting to provide free
and confidential contraceptive support to you. Press 1
if you would like me to call you back to discuss
contraception. Press 2 if you are comfortable with
using contraception and you do not need me to call
you back this time. Press 3 if you would prefer not to
receive any messages again’
Clients who indicate they would like to talk to a
counsellor, or who do not respond to the message
prompts, receive a call from an MSIC counsellor.
The counsellors provide individualised information on
contraceptive methods and advice if the client is ex-
periencing side effects from contraception. Clients are
advised to use condoms as dual protection from HIV
and sexually transmitted infections as appropriate.
Follow-up calls to clients are made during preferred
times indicated by the client on her registration form.
Clients in the intervention arm are also able to call
the MOTIF service at any time to request to speak
with a counsellor. Clients who opt to receive the OC
or injectable can opt in to receive additional reminder
messages appropriate to their method (that is, to start
a new packet of pills or when to receive a new injec-
tion). The sixth and final voice message provides
similar information to the first five, but also reminds
the client that this will be the last message they will
receive.
The MOTIF intervention is delivered by trained coun-
sellors at the MSIC head office in Phnom Penh. Voice
messages are scheduled and sent using the open-source
software programme ‘Verboice’, developed by InSTEDD
(instedd.org). Verboice has functionality with all the
mobile phone network operators. MSIC incurs the cost
of outgoing communication from the provider to client,
and clients incur any costs calling into the service
(the cost of a local call). The counsellor records informa-
tion on the voice messages sent, responses to messages
and outcomes of follow-up phone calls.
Control
Participants in the control group receive the current
existing SOC, but not the voice messages or follow-up
phone calls. Existing SOC includes: face-to-face post-
abortion counselling; a clinic follow-up appointment at 1
or 2 weeks; the clinic phone number and hotline phone
number: a toll-free help line for clients staffed by trained
counsellors at the MSIC head office.
Objectives
The objective of the study is to test whether additional
regular, structured, interactive mobile phone-based sup-
port improves use of PAFP. We hypothesise that the
intervention will remind clients about contraceptive
methods available, identify problems with side effects
early and provide appropriate support, and will boost
motivation to use PAFP, while reducing discontinuation
and unsafe method switching. Therefore we hypothesise
Figure 2 Summary of conceptual framework.
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that the intervention will increase use of PAFP com-
pared to clients receiving SOC (control).
Outcome measures
Baseline characteristics of study participants in both the
intervention and control groups will be compared with
those of the general clinic population. We will assess
recruitment rates, numbers assessed for eligibility
compared with numbers enrolled, and completeness of
follow-up.
Primary outcomes
The primary outcome measure is use of an effective
modern contraceptive method at 4 months post abor-
tion. We define effective modern methods to be those
associated with <10% 12-month pregnancy rates, as
commonly used: OC, injectable, implant, IUD, or per-
manent methods [18]. At 4 months, all trial participants
will be contacted by phone to collect self-report data on
all outcomes.
Participants are considered ‘users’ or ‘non-users’ of ef-
fective modern contraception according to method: im-
plant (participant currently has a sub-dermal implant);
IUD (participant currently has IUD inserted); injectable
(client has received injection within the previous
3 months); permanent method (client, or husband/part-
ner has had sterilisation or vasectomy procedure); OC
(participant reports having taken pill within 24 h of
interview or, if on 7-day break, took the last pill accord-
ing to instructions). Although self-reported data on
contraception use are considered less reliable, and prone
to social desirability bias, it is the standard approach for
contraception research and it will provide data that are
comparable to previous studies [19,20].
In order to assess the validity of self-reported data, a
reliability study based on approximately 50 participants
recruited from the clinics near Phnom Penh will be con-
ducted. Participants who have already provided self-
report follow-up who were recruited from Chbar Ambov
and Takmao clinics will be contacted in sequential order,
and requested to attend the clinic of their choice for
face-to-face follow-up for objective measurement on all
contraception outcomes. This will include urine preg-
nancy testing and measures of contraceptive adherence
(presence of sub-dermal implant, or documentary evi-
dence of insertion, clinical examination to identify coil
threads or documentary evidence of insertion, documen-
tary evidence of injection within the previous 3 months,
documentary evidence of sterilisation, pill counts defined
as >9% of pills taken since last prescription dispensed).
Secondary outcomes
Secondary outcome measures include self-reported preg-
nancy, repeat abortion, contraception use over the
4-month post-abortion period (to estimate point preva-
lence of contraception use at any given time and contra-
ceptive discontinuation rates), and involvement in any
domestic abuse or road traffic accidents (RTA). RTAs
are rare, but the only adverse health effect of cell phone
use for which there is evidence [21].
Sample size
Analysis of 2011 MSIC clinic data indicated that the
proportion of clients using an effective contraceptive
method at 2 weeks post abortion was 44%. The trial will
involve the same population so it is reasonable to as-
sume similar PAFP use in the control group. Aggregate
demographic and health, and Cambodian, survey data
indicate that around 30% of women using hormonal
methods and 10% using the coil discontinue within
1 year, many before 3 months of use [22,23]. Contracep-
tion use, repeat pregnancy or abortion rates in MSIC
clinics after 2 weeks are not known. Based on aggregate
data, we anticipate 20% discontinuation from 2-week ac-
ceptance, and therefore 35% of clients will be using an
effective method at 4 months post abortion.
The trial has been designed to detect an increase of
13% in contraceptive use at 4 months as results from
previous mHealth HIV adherence and face-to-face
contraception adherence interventions suggest that it is
reasonable to anticipate an effect of this size. Canto De
Cetina (2001) reported a 26% decrease in injectable dis-
continuation at 1 year with an intervention providing
structured face-to-face counselling versus routine infor-
mation [24]. Lester (2010) reported a 12% increase in
self-reported adherence among those receiving the
mHealth intervention compared to routine care [15].
In the four trial clinics there were over 1,500 abortions
during a 3-month period in 2011, therefore even ac-
counting for refusals and reduced recruitment due to
clinic staff time pressure, we believe it will be possible to
recruit 500 participants over a 3-month period. A trial
of 500 has 80% power to detect a difference in contra-
ceptive use of 35% vs. 48% (that is, relative risk 1.4) at
the 5% significance level (that is, P <0.05). It is not pos-
sible to adequately power the study for the rare second-
ary outcomes of repeat pregnancy and abortion.
Data collection
At present, around 50% of clients do not return to the
clinic for any reason after attending for abortion, there-
fore all trial participants will be actively followed up by a
RA to assess outcome measures. Data collection tools
include baseline and follow-up questionnaires: designed
in English, translated to Khmer and administered by
local RAs fluent in Khmer. The baseline questionnaire
contains questions to collect information on contact
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details, demographics, reproductive history and plans,
circumstances of current abortion and mobile phone
use.
The follow-up questionnaire contains questions to col-
lect information on changes in demographics, current
contraception use, contraception use over the 4-month
post-abortion period, and any reported domestic abuse
or RTA that could have resulted from mobile phone use.
In addition to self-reported measures, clients that attend
the clinic for face-to-face follow-up will be offered urine
pregnancy testing and objective assessment of contra-
ceptive use by a clinically trained RA.
The follow-up questionnaire assesses births, pregnan-
cies, contraceptive use and discontinuation over a period
of time using a similar format to that used in the CDHS.
Analysis plan
Analysis of primary and secondary outcomes
We will report the trial according to the CONSORT
standards for reporting RCTs. This is a behavioural
intervention unlikely to produce adverse effects, so ana-
lysis will be undertaken once the 4-month follow-up has
been completed.
Intention-to-treat (ITT) principles will be used for
primary outcome analysis; therefore all participants will
be analysed according to the arm to which they were
randomised. During ITT analysis, participants lost to
follow-up, resulting in missing contraceptive use out-
come data at 4 months, will be considered non-users.
Sensitivity and per-protocol analysis
We will conduct an additional sensitivity analysis inclu-
ding only participants who completed the 4-month
follow-up. Per-protocol analysis will be undertaken to
assess the impact of the intervention among those who
actively participated in the intervention. Participants
who respond to three or more of the six voice messages
over the intervention period will be considered highly
protocol adherent. Participants who respond to between
one and three messages will considered less protocol ad-
herent. Those who never responded to a voice message
will be considered as never responding and not included
in the sensitivity analysis.
Sub-group analysis
We will undertake exploratory sub-group analyses to as-
sess evidence for whether the effect of the intervention
varies according to age, urban versus rural residence,
level of education, and socioeconomic status. If statisti-
cally significant overall heterogeneity is identified then
relative risks and 99% confidence intervals will be
estimated.
Statistical methods
For the primary outcome and secondary outcomes we
will estimate risk ratios with 95% confidence intervals.
We will calculate the sensitivity and specificity of self-
reported contraception use as compared to objective
measurement, and comment on any limitations of the
respective methods of data collection. We will undertake
Kaplan-Meier survival analysis to compare contraceptive
discontinuation rates. Analysis will be conducted using
STATA (Table 1) [25].
Additional analysis
Data arising from the intervention
We will provide a descriptive analysis of data generated
by the intervention to include number of voice message
and phone interactions, response to voice messages, and
time spent on phone calls, to facilitate description of
problems and issues. Additionally, at the end of the trial,
the costs of the intervention (training, human resources,
phone costs and so on) will be estimated.
Qualitative interviews
We will conduct around 15 to 20 qualitative interviews
with participants who received the intervention. Partici-
pants for interview will be selected purposively to in-
clude those who did or did not appear to respond to the
intervention: both users and non-users of contraception.
The interviews will explore participants’ experience of
the intervention, aiming to identify active components
of the intervention, and seek recommendations for im-
provements. Interviews will be recorded and transcribed
and a simple thematic analysis undertaken. We will use
the findings to inform any adjustments to the interven-
tion after the trial.
Analysis of long-term follow-up at 12 and 24 months
The main purpose of taking contraception is to avoid
unwanted pregnancy. While it is likely that few partici-
pants will report repeat pregnancy and/or abortion at
4 months, differences in these important outcomes may
become apparent over a longer period of time. During
trial recruitment, participants are given the option to
consent for additional follow-up of primary and second-
ary outcomes at 12 and 24 months. This additional
follow-up will be dependent on receiving additional
funding and participants will be informed whether this
additional follow-up is likely to occur at the end of the
study.
Ethics
The trial is being conducted in accordance with the
principles of Good Clinical Practice [26]. Ethical ap-
proval for the study protocol was granted by the
LSHTM ethics committee, the MSI ethics committee
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and the Cambodia Human Research Ethics Committee.
The MOTIF trial is registered with ClinicalTrials.gov,
number: NCT01823861 [27].
All participants provide written consent before enrolling
in the trial or commencing the follow-up interview. All cli-
ent records, written, recorded and transcribed data are
stored securely. No names of participants (or others men-
tioned) or locations will be used in the analysis or report
writing. Confidentiality will be maintained by assigning
coded identifiers to participant names (with a master list
stored separately). Participants are able to withdraw from
the study at any point. Any participants raising a personal
sexual issue or consequences arising from other people lis-
tening to voice messages (for example, an argument or
violence) will be linked into appropriate services, either at
MSIC, or other local organisations.
Participants are reimbursed to compensate for ex-
penses related to face-to-face clinic follow-up, but not
for participation in the trial. Participants are not pro-
vided with mobile phones or airtime.
Discussion
The MOTIF trial will provide rigorous evaluation of a
novel mobile phone-based intervention to support PAFP;
and will contribute towards the evidence base on
mHealth interventions for contraception. The MOTIF
trial is unique in a number of ways.
First, to our knowledge this is the first RCT of a mo-
bile phone-based intervention using voice messages to
support PAFP. Given the paucity of evidence for effect-
ive interventions for PAFP in low-income settings, fur-
ther research in this area is important. The MOTIF trial
has been carefully designed to minimise bias and collect
information on important health outcomes, while taking
into account the sensitivities of undertaking research
with post-abortion clients. Due to the nature of the
intervention, the trial can only be single-blind and study
participants will be aware of intervention allocation.
However, allocation will be concealed to clinicians and
RAs working on the trial.
Second, it examines the interventions effect on both
users and non-users of contraception, on a range of
contraceptive methods over a period of time. Previous
mHealth contraception interventions have often been
focused on one particular method, often the OC. In
addition to the OC, the MOTIF intervention will
promote long-acting methods which are associated with
less user-failure. We believe that given high rates of
Table 1 Outcome measures and methods of analysis
Outcome Outcome measure Method of analysis
1. Primary
Use of an effective modern method
of contraception at 4 months
Self-report (binary) Chi-squared test
Objectivea (binary)
2. Secondary
Pregnancy Self-report (binary) (0, 1 or more) Chi-squared test
Urine pregnancy testa (binary)
Repeat abortion Self-report (binary) (0, 1 or more) Chi-squared test
Effective modern contraception
use over 4-month period
Self-report (binary) (<80%, >80%) Chi-squared test
Contraceptive discontinuation Discontinuation after starting contraceptive
method (time to event)
Kaplan-Meier survival analysis
Involvement in road traffic accident Self-report (binary) Chi-squared test
Domestic abuse Self-report (binary) Chi-squared test
3. Sensitivity and per-protocol analysis
Participants that completed follow-up All outcomes Chi-squared/T-test/logistic and linear regression
Clustering among participants from one clinic
Per-protocol analysis
4. Sub-group analysis All outcomes
Age
Urban versus rural residence Logistic/linear regression
Level of education
Socioeconomic status
Follow-up at 4 months for all participants will comprise a telephone interview conducted by a research assistant.
aApproximately 50 participants from one clinic will be requested to attend for face-to-face follow-up for objective measurement of contraceptive outcomes.
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dissatisfaction with methods, leading to discontinuation,
interventions that promote safe method switching, as
well as support for clients experiencing side effects, will
lead to increased contraceptive use overall and reduced
unintended pregnancy.
Third, to our knowledge, this is one of the first RCTs
of a mobile phone-based intervention to support contra-
ception use in a low-income setting. To date, most RCTs
of mHealth interventions to support contraception use
have been conducted in the USA, the exception being
the mAssist trial in South Africa [13]. Other mobile
phone-based contraception initiatives that have been
launched and scaled up in low-income settings include
Mobile for Reproductive Health (m4RH), Cycle Tel,
Mobile Alliance for Maternal Action (MAMA), each with
different approaches to the intervention and evaluation,
but limited evidence of health impacts to date [28-30].
No single trial or initiative will answer the question of
whether mHealth interventions are effective in suppor-
ting contraception use and we also recognise that
mHealth is a dynamic area, with rapid changes in both
technology and the techno-literacy of populations;
hence, what works or does not work now may not hold
true in a few years’ time. The MOTIF trial will provide
evidence on the effectiveness of voice messages to
support contraception use in populations with limited
literacy, and findings could be generalisable to similar
populations in different settings. Therefore, in addition
to publishing the findings from our statistical analysis
we intend to report on our analysis of why the interven-
tion did or did not work, what BCTs appear to be the
‘active components’ of the intervention, technological
successes and challenges, and cost and resource implica-
tions for scale-up of the intervention. This should ensure
that the learning from this study will be of the greatest
possible value to other organisations or researchers seek-
ing to develop similar interventions.
Trial status
Recruiting.
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